Cassava Sciences: My Bullish Take On Biomarkers And CTAD Data (NASDAQ:SAVA)

Young male chemist examining medical sample through a microscope in laboratory.

skynesher/E+ via Getty Images


The bears and the bulls both have had their way with the stock of Cassava Sciences (NASDAQ:SAVA) and probably will continue to do so going forward. The original science surrounding its drug candidate is

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *